Tag: artificial intelligence in oncology market insights

  • Artificial Intelligence In Oncology Market Expected To Reach $10.24 Billion By 2030 As Growth Accelerates At 34.5% CAGR

    Artificial Intelligence In Oncology Market Expected To Reach $10.24 Billion By 2030 As Growth Accelerates At 34.5% CAGR

    Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.

    Artificial Intelligence In Oncology Market Size Outlook: How Fast Will Revenue Grow Through 2030?

    In the realm of artificial intelligence within oncology, a significant expansion has been observed lately. Projections indicate a leap from a market valuation of $2.35 billion in 2025 to $3.13 billion in 2026, propelled by a formidable compound annual growth rate of 33.4%. This impressive growth trajectory in the preceding period has been fueled by a confluence of factors including the escalating worldwide prevalence of cancer, the proliferation of research endeavors focused on oncology, a broader uptake of digital pathology methodologies, an increased reliance on diagnostic tools informed by data analytics in cancer care, and substantial investments made in sophisticated oncology infrastructure.

    The oncology sector’s artificial intelligence market is poised for remarkable expansion in the coming years, projecting a valuation of $10.25 billion by 2030 with a compound annual growth rate (CAGR) of 34.5%. This upward trajectory is fueled by several key factors, including the wider embrace of precision oncology approaches, a heightened demand for tailored cancer treatments, the expanded application of AI within clinical oncology studies, greater synergy between genomic data and AI systems, and increased funding directed towards AI ventures specializing in oncology. Significant developments anticipated during this period encompass the greater utilization of AI-powered tools for cancer identification, the increased application of AI in refining treatment strategies, the accelerated integration of AI into the pharmaceutical research and development pipeline for cancer drugs, the proliferation of predictive analytics in oncology, and a reinforced emphasis on leveraging AI for precision oncology initiatives.

    Download A Free Sample Report For Comprehensive Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=13130&type=smp

    Artificial Intelligence In Oncology Market Growth Drivers: What Factors Are Accelerating Expansion?

    Anticipated increases in cancer diagnoses are poised to stimulate the expansion of the AI in oncology sector moving ahead. This complex category of illnesses is defined by the unrestricted proliferation and multiplication of aberrant cells within the organism. The incorporation of artificial intelligence into the field of oncology offers the capability to transform cancer treatment paradigms, enhancing accuracy, tailoring interventions, and boosting overall efficacy. Illustratively, statistics from the American Cancer Society Inc., a non-profit health entity headquartered in the US, indicated a rise in projected new cancer cases from 1.8 million to 1.9 million in 2023. Consequently, this upward trend in cancer occurrences is serving as a primary catalyst for the burgeoning AI in oncology market.

    #Artificial Intelligence In Oncology Market Segment Landscape And Growth Potential

    The artificial intelligence in oncology market covered in this report is segmented –

    1) By Component: Software Solutions, Hardware, Services

    2) By Treatment Type: Chemotherapy, Radiotherapy, Immunotherapy, Other Treatment Types

    3) By Cancer Type: Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Brain Tumor, Other Cancer Types

    4) By Application: Cancer Detection, Drug Discovery, Drug Development, Other Applications

    5) By End-Users: Hospitals, Diagnostic Centers, Pharmaceutical Companies, Research Institutes, Other End Users

    Subsegments:

    1) By Software Solutions: Diagnostic Software, Treatment Planning Software, Patient Management Software, Data Analytics Platforms

    2) By Hardware: AI-Enabled Imaging Devices, High-Performance Computing Systems

    3) By Services: Consulting Services, Integration Services, Maintenance And Support Services

    Artificial Intelligence In Oncology Market Trends: What Is Shaping Future Industry Growth?

    Leading players within the AI in oncology market are concentrating their efforts on creating cutting-edge software solutions, including cloud-based platforms, to boost effectiveness and deliver superior outcomes. These cloud-based software offerings are instrumental in oncology AI by furnishing a robust, adaptable, and readily available environment for the complex processing and examination of extensive medical datasets. As an illustration, Illumina Inc., a prominent US biotechnology firm, introduced Connected Insights in March 2023, a novel cloud-based software designed to facilitate advanced analysis specifically for oncology applications. By incorporating external knowledge repositories, Connected Insights simplifies the interpretation and reporting of outcomes derived from diverse assay methodologies, thereby empowering laboratories to broaden their adoption of Next-Generation Sequencing (NGS) and accelerate the delivery of clinical reports.

    Artificial Intelligence In Oncology Market Competitive Landscape: Who Are The Leading Companies?

    Major companies operating in the artificial intelligence in oncology market are Azra AI, IBM Corporation, Siemens Healthcare GmbH, GE HealthCare, NVIDIA Corporation, Digital Diagnostics Inc., ConcertAI Inc., PathAI Inc., Median Technologies SA, Kheiron Medical Technologies Ltd, Tempus Labs Inc., Paige AI Inc., Prognos Health Inc., Enlitic, Inspirata Inc., Proscia Inc., Deep 6 AI Inc., Intel Corporation, Zebra Medical Vision, Ibex Medical Analytics, Nanox Imaging Ltd., Berg LLC

    Access The Complete Artificial Intelligence In Oncology Market Report:

    https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-oncology-global-market-report

    Artificial Intelligence In Oncology Market Global Footprint: Which Region Holds Market Leadership?

    North Americawas the largest region in the AI in oncology market in 2025. Asia-Pacificis expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence in oncology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas: +1 310-496-7795

    Asia: +44 7882 955267 & +91 8897263534

    Europe: +44 7882 955267

    Email us at: marketing@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Artificial Intelligence In Oncology Market Insights Exploring Expansion Opportunities Through 2030

    Artificial Intelligence In Oncology Market Insights Exploring Expansion Opportunities Through 2030

    The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

    By 2030, How Much Growth In Market Size Is Expected For The Artificial Intelligence In Oncology Market?

    The artificial intelligence in oncology market has seen substantial growth in its size over recent years. Forecasts indicate it will expand from $2.35 billion in 2025 to $3.13 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 33.4%. This historical expansion is attributable to factors such as increasing global cancer incidence rates, the development of oncology research initiatives, broader adoption of digital pathology, the growing application of data-driven cancer diagnostics, and investments in advanced oncology infrastructure.

    The artificial intelligence in oncology market is projected to experience substantial expansion over the upcoming years. This market is anticipated to reach a valuation of $10.25 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 34.5%. Key drivers propelling this growth during the forecast period include the escalating uptake of precision oncology solutions, a surge in demand for personalized cancer therapies, the broadening application of AI in clinical oncology trials, the expanding integration of genomics with AI platforms, and increasing investments directed towards oncology-focused AI startups. Prominent trends expected throughout this period encompass the growing adoption of AI-based tools for cancer detection, the increasing utilization of AI in optimizing treatment planning, the deeper integration of AI into drug discovery and development processes, the expansion of predictive oncology analytics, and an intensified focus on precision oncology applications.

    Download A Free Sample Report For Comprehensive Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=13130&type=smp

    Which Growth Drivers Are Expected To Support The Artificial Intelligence In Oncology Market Forward?

    The increasing occurrence of cancer diagnoses is anticipated to stimulate the expansion of the AI in oncology market. This condition, cancer, represents a multifaceted set of ailments marked by the unchecked multiplication and separation of anomalous cells within the body. The embedding of AI in oncology holds the promise to transform patient care for cancer, rendering it more exact, individually tailored, and streamlined. As an illustration, in 2023, a publication by the American Cancer Society Inc., a voluntary health organization based in the US, reported an increase in the projected new cancer cases from 1.8 million to 1.9 million. Consequently, the growing frequency of cancer cases is serving as a catalyst for the AI in oncology market’s development.

    How Is The Artificial Intelligence In Oncology Market Distributed Across Key Segments?

    The artificial intelligence in oncology market covered in this report is segmented –

    1) By Component: Software Solutions, Hardware, Services

    2) By Treatment Type: Chemotherapy, Radiotherapy, Immunotherapy, Other Treatment Types

    3) By Cancer Type: Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Brain Tumor, Other Cancer Types

    4) By Application: Cancer Detection, Drug Discovery, Drug Development, Other Applications

    5) By End-Users: Hospitals, Diagnostic Centers, Pharmaceutical Companies, Research Institutes, Other End Users

    Subsegments:

    1) By Software Solutions: Diagnostic Software, Treatment Planning Software, Patient Management Software, Data Analytics Platforms

    2) By Hardware: AI-Enabled Imaging Devices, High-Performance Computing Systems

    3) By Services: Consulting Services, Integration Services, Maintenance And Support Services

    Which Trends Are Guiding The Development Of The Artificial Intelligence In Oncology Market?

    Companies operating within the AI in the oncology market are primarily focused on developing cutting-edge software, such as cloud-based solutions, to improve their performance and offer enhanced services. Cloud-based software is essential for AI applications in oncology because it provides a scalable, adaptable, and accessible platform for managing and analyzing large volumes of medical information. For instance, in March 2023, Illumina Inc., a US-based biotechnology company, unveiled Connected Insights, a new cloud-based software designed for tertiary analysis in oncology applications. By integrating external knowledge bases, Connected Insights simplifies the interpretation and reporting of results from various assay types, allowing laboratories to expand their utilization of NGS (Next-Generation Sequencing) and accelerate the turnaround time for clinical reporting.

    Which Organizations Are Involved In The Artificial Intelligence In Oncology Market?

    Major companies operating in the artificial intelligence in oncology market are Azra AI, IBM Corporation, Siemens Healthcare GmbH, GE HealthCare, NVIDIA Corporation, Digital Diagnostics Inc., ConcertAI Inc., PathAI Inc., Median Technologies SA, Kheiron Medical Technologies Ltd, Tempus Labs Inc., Paige AI Inc., Prognos Health Inc., Enlitic, Inspirata Inc., Proscia Inc., Deep 6 AI Inc., Intel Corporation, Zebra Medical Vision, Ibex Medical Analytics, Nanox Imaging Ltd., Berg LLC

    Access The Complete Artificial Intelligence In Oncology Market Report:

    https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-oncology-global-market-report

    Which Region Is The Primary Market For The Artificial Intelligence In Oncology Market?

    North America was the largest region in the AI in oncology market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence in oncology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Access Artificial Intelligence In Oncology Market Report for Deeper Competitive Insights

    https://www.thebusinessresearchcompany.com/customise?id=13130&type=smp

    Browse Through More Reports Similar to the Global Artificial Intelligence In Oncology Market 2026, By The Business Research Company

    Artificial Intelligence In Cancer Diagnostics Global Market Report 2026

    https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-cancer-diagnostics-global-market-report

    Artificial Intelligence In Medicine Global Market Report 2026

    https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-medicine-global-market-report

    Ai In Cancer Diagnostics Global Market Report 2026

    https://www.thebusinessresearchcompany.com/report/ai-in-cancer-diagnostics-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas: +1 310-496-7795

    Asia: +44 7882 955267 & +91 8897263534

    Europe: +44 7882 955267

    Email us at: marketing@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Artificial Intelligence In Oncology Market Insights Exploring Expansion Opportunities Through 2030

    Artificial Intelligence In Oncology Market Insights Exploring Expansion Opportunities Through 2030

    The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

    By 2030, How Much Growth In Market Size Is Expected For The Artificial Intelligence In Oncology Market?

    The artificial intelligence in oncology market has seen substantial growth in its size over recent years. Forecasts indicate it will expand from $2.35 billion in 2025 to $3.13 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 33.4%. This historical expansion is attributable to factors such as increasing global cancer incidence rates, the development of oncology research initiatives, broader adoption of digital pathology, the growing application of data-driven cancer diagnostics, and investments in advanced oncology infrastructure.

    The artificial intelligence in oncology market is projected to experience substantial expansion over the upcoming years. This market is anticipated to reach a valuation of $10.25 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 34.5%. Key drivers propelling this growth during the forecast period include the escalating uptake of precision oncology solutions, a surge in demand for personalized cancer therapies, the broadening application of AI in clinical oncology trials, the expanding integration of genomics with AI platforms, and increasing investments directed towards oncology-focused AI startups. Prominent trends expected throughout this period encompass the growing adoption of AI-based tools for cancer detection, the increasing utilization of AI in optimizing treatment planning, the deeper integration of AI into drug discovery and development processes, the expansion of predictive oncology analytics, and an intensified focus on precision oncology applications.

    Download A Free Sample Report For Comprehensive Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=13130&type=smp

    Which Growth Drivers Are Expected To Support The Artificial Intelligence In Oncology Market Forward?

    The increasing occurrence of cancer diagnoses is anticipated to stimulate the expansion of the AI in oncology market. This condition, cancer, represents a multifaceted set of ailments marked by the unchecked multiplication and separation of anomalous cells within the body. The embedding of AI in oncology holds the promise to transform patient care for cancer, rendering it more exact, individually tailored, and streamlined. As an illustration, in 2023, a publication by the American Cancer Society Inc., a voluntary health organization based in the US, reported an increase in the projected new cancer cases from 1.8 million to 1.9 million. Consequently, the growing frequency of cancer cases is serving as a catalyst for the AI in oncology market’s development.

    How Is The Artificial Intelligence In Oncology Market Distributed Across Key Segments?

    The artificial intelligence in oncology market covered in this report is segmented –

    1) By Component: Software Solutions, Hardware, Services

    2) By Treatment Type: Chemotherapy, Radiotherapy, Immunotherapy, Other Treatment Types

    3) By Cancer Type: Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Brain Tumor, Other Cancer Types

    4) By Application: Cancer Detection, Drug Discovery, Drug Development, Other Applications

    5) By End-Users: Hospitals, Diagnostic Centers, Pharmaceutical Companies, Research Institutes, Other End Users

    Subsegments:

    1) By Software Solutions: Diagnostic Software, Treatment Planning Software, Patient Management Software, Data Analytics Platforms

    2) By Hardware: AI-Enabled Imaging Devices, High-Performance Computing Systems

    3) By Services: Consulting Services, Integration Services, Maintenance And Support Services

    Which Trends Are Guiding The Development Of The Artificial Intelligence In Oncology Market?

    Companies operating within the AI in the oncology market are primarily focused on developing cutting-edge software, such as cloud-based solutions, to improve their performance and offer enhanced services. Cloud-based software is essential for AI applications in oncology because it provides a scalable, adaptable, and accessible platform for managing and analyzing large volumes of medical information. For instance, in March 2023, Illumina Inc., a US-based biotechnology company, unveiled Connected Insights, a new cloud-based software designed for tertiary analysis in oncology applications. By integrating external knowledge bases, Connected Insights simplifies the interpretation and reporting of results from various assay types, allowing laboratories to expand their utilization of NGS (Next-Generation Sequencing) and accelerate the turnaround time for clinical reporting.

    Which Organizations Are Involved In The Artificial Intelligence In Oncology Market?

    Major companies operating in the artificial intelligence in oncology market are Azra AI, IBM Corporation, Siemens Healthcare GmbH, GE HealthCare, NVIDIA Corporation, Digital Diagnostics Inc., ConcertAI Inc., PathAI Inc., Median Technologies SA, Kheiron Medical Technologies Ltd, Tempus Labs Inc., Paige AI Inc., Prognos Health Inc., Enlitic, Inspirata Inc., Proscia Inc., Deep 6 AI Inc., Intel Corporation, Zebra Medical Vision, Ibex Medical Analytics, Nanox Imaging Ltd., Berg LLC

    Access The Complete Artificial Intelligence In Oncology Market Report:

    https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-oncology-global-market-report

    Which Region Is The Primary Market For The Artificial Intelligence In Oncology Market?

    North America was the largest region in the AI in oncology market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence in oncology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Access Artificial Intelligence In Oncology Market Report for Deeper Competitive Insights

    https://www.thebusinessresearchcompany.com/customise?id=13130&type=smp

    Browse Through More Reports Similar to the Global Artificial Intelligence In Oncology Market 2026, By The Business Research Company

    Artificial Intelligence In Cancer Diagnostics Global Market Report 2026

    https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-cancer-diagnostics-global-market-report

    Artificial Intelligence In Medicine Global Market Report 2026

    https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-medicine-global-market-report

    Ai In Cancer Diagnostics Global Market Report 2026

    https://www.thebusinessresearchcompany.com/report/ai-in-cancer-diagnostics-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas: +1 310-496-7795

    Asia: +44 7882 955267 & +91 8897263534

    Europe: +44 7882 955267

    Email us at: marketing@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • AI in Oncology Market Growth Accelerates with Rising Global Cancer Incidence

    AI in Oncology Market Growth Accelerates with Rising Global Cancer Incidence

    The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

    What Is The Estimated Market Size Of The Artificial Intelligence In Oncology Market In 2026, And How Will Its Value Evolve By 2030?

    The market for artificial intelligence in oncology has experienced rapid expansion over recent years. This market is projected to expand from $2.35 billion in 2025 to $3.13 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 33.4%. Historically, this growth can be attributed to several factors including an increase in global cancer incidence rates, the proliferation of oncology research initiatives, wider adoption of digital pathology, the growing application of data-driven cancer diagnostics, and significant investments in advanced oncology infrastructure.

    The artificial intelligence in oncology market size is projected to experience substantial growth over the coming years. This market is set to reach $10.25 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 34.5%. This anticipated expansion during the forecast period stems from factors such as the increasing uptake of precision oncology solutions, the growing need for personalized cancer therapies, the broadened application of AI in clinical oncology trials, the deeper integration of genomics with AI platforms, and a rise in investments directed towards oncology-focused AI startups. Key developments expected during this period involve a greater acceptance of AI-based tools for cancer detection, more frequent utilization of AI in optimizing treatment plans, an expanding integration of AI into drug discovery and development processes, the wider application of predictive oncology analytics, and a heightened emphasis on precision oncology applications.

    Access Your Free Sample Report For In-Depth Market Analysis:

    https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-oncology-global-market-report

    What Significant Factors Are Influencing The Artificial Intelligence In Oncology Market Expansion?

    The increasing prevalence of cancer diagnoses is projected to stimulate the expansion of the AI in oncology market moving forward. Cancer is a complex condition defined by the uncontrolled multiplication and division of abnormal cells within the body. The adoption of AI in oncology holds the potential to revolutionize patient care by enhancing its precision, personalization, and efficiency. As an illustration, in 2023, a report by the American Cancer Society Inc., a US-based voluntary health organization, showed that the estimated number of new cancer cases climbed from 1.8 million to 1.9 million. This upward trend in cancer incidence is consequently propelling the growth of the AI in oncology market.

    How Are Segments Identified Within The Artificial Intelligence In Oncology Market Segment Framework?

    The artificial intelligence in oncology market covered in this report is segmented –

    1) By Component: Software Solutions, Hardware, Services

    2) By Treatment Type: Chemotherapy, Radiotherapy, Immunotherapy, Other Treatment Types

    3) By Cancer Type: Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Brain Tumor, Other Cancer Types

    4) By Application: Cancer Detection, Drug Discovery, Drug Development, Other Applications

    5) By End-Users: Hospitals, Diagnostic Centers, Pharmaceutical Companies, Research Institutes, Other End Users

    Subsegments:

    1) By Software Solutions: Diagnostic Software, Treatment Planning Software, Patient Management Software, Data Analytics Platforms

    2) By Hardware: AI-Enabled Imaging Devices, High-Performance Computing Systems

    3) By Services: Consulting Services, Integration Services, Maintenance And Support Services

    What Trends Are Affecting The Direction Of The Artificial Intelligence In Oncology Market?

    Key companies operating within the AI in the oncology market are prioritizing the creation of cutting-edge software, such as cloud-based platforms, to improve their efficiency and offer superior solutions. Cloud-based software is vital for AI applications in oncology, serving as a scalable, adaptable, and easily accessible platform for processing and analyzing extensive medical datasets. For instance, in March 2023, Illumina Inc., a US-based biotechnology company, unveiled Connected Insights, a new cloud-based software specifically for tertiary analysis in oncology applications. By integrating external knowledge bases, Connected Insights streamlines the interpretation and reporting of results from various assay types, empowering labs to expand their utilization of NGS (Next-Generation Sequencing) and significantly reduce the turnaround time for clinical reporting.

    Who Are The Companies Competing Within The Artificial Intelligence In Oncology Market?

    Major companies operating in the artificial intelligence in oncology market are Azra AI, IBM Corporation, Siemens Healthcare GmbH, GE HealthCare, NVIDIA Corporation, Digital Diagnostics Inc., ConcertAI Inc., PathAI Inc., Median Technologies SA, Kheiron Medical Technologies Ltd, Tempus Labs Inc., Paige AI Inc., Prognos Health Inc., Enlitic, Inspirata Inc., Proscia Inc., Deep 6 AI Inc., Intel Corporation, Zebra Medical Vision, Ibex Medical Analytics, Nanox Imaging Ltd., Berg LLC

    Get The Full Artificial Intelligence In Oncology Market Report:

    https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-oncology-global-market-report

    Which Geographic Region Dominates The Artificial Intelligence In Oncology Market?

    North America was the largest region in the AI in oncology market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence in oncology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request A Customized Artificial Intelligence In Oncology Market Report For Competitive Insights:

    https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-oncology-global-market-report

    Browse Through More Reports Similar to the Global Artificial Intelligence In Oncology Market 2026, By The Business Research Company

    Ai In Cancer Diagnostics Market Report 2026

    https://www.thebusinessresearchcompany.com/report/ai-in-cancer-diagnostics-global-market-report

    Artificial Intelligence In Cancer Diagnostics Market Report 2026

    https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-cancer-diagnostics-global-market-report

    Artificial Intelligence In Medicine Market Report 2026

    https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-medicine-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Artificial Intelligence In Oncology Market Insights Highlighting Opportunities and Drivers Supporting Growth to 2030

    Artificial Intelligence In Oncology Market Insights Highlighting Opportunities and Drivers Supporting Growth to 2030

    The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

    How Much Is The Artificial Intelligence In Oncology Market Expected To Grow In Terms Of Market Value Between 2026 And 2030?

    The market size for artificial intelligence in oncology has experienced rapid expansion over recent years. Forecasts indicate it will expand from $2.35 billion in 2025 to $3.13 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 33.4%. Historically, this growth can be ascribed to several factors including rising global cancer incidence rates, an increase in oncology research initiatives, wider adoption of digital pathology, the growing application of data-driven cancer diagnostics, and significant investments in advanced oncology infrastructure.

    The artificial intelligence in oncology market size is set for substantial growth in the upcoming years. It is projected to expand to $10.25 billion by 2030, achieving a compound annual growth rate (CAGR) of 34.5%. This growth throughout the forecast period can be attributed to the increasing uptake of precision oncology solutions, a rising demand for personalized cancer therapies, the expanding use of AI in clinical oncology trials, the growing integration of genomics with AI platforms, and increasing investments in oncology-focused AI startups. Prominent trends expected during this period include the rising adoption of AI-based cancer detection tools, an increased application of AI in optimizing treatment planning, the deepening integration of AI in drug discovery and development, the expansion of predictive oncology analytics, and an enhanced focus on precision oncology applications.

    Download the Free Sample Report to Explore Key Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=13130&type=smp

    What Key Drivers Are Influencing The Growth Of The Artificial Intelligence In Oncology Market?

    The increasing occurrence of cancer is anticipated to fuel the expansion of the AI in oncology market in the future. Cancer constitutes a sophisticated category of illnesses marked by the unregulated proliferation and splitting of unusual cells within the body. Incorporating AI into oncology holds the promise of transforming cancer treatment, enhancing its precision, individualization, and effectiveness. A concrete example is that in 2023, a report from the American Cancer Society Inc., a US-based voluntary health organization, indicated an increase in estimated new cancer cases from 1.8 million to 1.9 million. Consequently, the growing frequency of cancer cases is propelling the growth of the AI in oncology market.

    What Major Segment Divisions Exist Within The Artificial Intelligence In Oncology Market?

    The artificial intelligence in oncology market covered in this report is segmented –

    1) By Component: Software Solutions, Hardware, Services

    2) By Treatment Type: Chemotherapy, Radiotherapy, Immunotherapy, Other Treatment Types

    3) By Cancer Type: Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Brain Tumor, Other Cancer Types

    4) By Application: Cancer Detection, Drug Discovery, Drug Development, Other Applications

    5) By End-Users: Hospitals, Diagnostic Centers, Pharmaceutical Companies, Research Institutes, Other End Users

    Subsegments:

    1) By Software Solutions: Diagnostic Software, Treatment Planning Software, Patient Management Software, Data Analytics Platforms

    2) By Hardware: AI-Enabled Imaging Devices, High-Performance Computing Systems

    3) By Services: Consulting Services, Integration Services, Maintenance And Support Services

    How Are Trends Transforming The Artificial Intelligence In Oncology Market Landscape?

    Key companies operating in the AI in the oncology market are concentrating on producing cutting-edge software, such as cloud-based solutions, to heighten their effectiveness and provide better services. Cloud-based software is fundamental to AI applications in oncology, offering a scalable, adaptable, and accessible platform for processing and analyzing large volumes of medical data. For instance, in March 2023, Illumina Inc., a US-based biotechnology company, introduced Connected Insights, a new cloud-based software facilitating tertiary analysis for oncology applications. Through the integration of external knowledge bases, Connected Insights streamlines the interpretation and reporting of results from diverse assay types, allowing labs to expand their utilization of NGS (Next-Generation Sequencing) and quicken the turnaround time for clinical reporting.

    Which Companies Are Leading Innovation In The Artificial Intelligence In Oncology Market?

    Major companies operating in the artificial intelligence in oncology market are Azra AI, IBM Corporation, Siemens Healthcare GmbH, GE HealthCare, NVIDIA Corporation, Digital Diagnostics Inc., ConcertAI Inc., PathAI Inc., Median Technologies SA, Kheiron Medical Technologies Ltd, Tempus Labs Inc., Paige AI Inc., Prognos Health Inc., Enlitic, Inspirata Inc., Proscia Inc., Deep 6 AI Inc., Intel Corporation, Zebra Medical Vision, Ibex Medical Analytics, Nanox Imaging Ltd., Berg LLC

    Read the full artificial intelligence in oncology market report here:

    https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-oncology-global-market-report

    Which Region Is Expected To Register The Fastest Growth In The Artificial Intelligence In Oncology Market?

    North America was the largest region in the AI in oncology market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence in oncology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request A Tailored Artificial Intelligence In Oncology Market Research Report For Competitive Advantage:

    https://www.thebusinessresearchcompany.com/customise?id=13130&type=smp

    Browse Through More Reports Similar to the Global Artificial Intelligence In Oncology Market 2026, By The Business Research Company

    Artificial Intelligence In Cancer Diagnostics Global Market Report

    https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-cancer-diagnostics-global-market-report

    Artificial Intelligence In Medicine Global Market Report

    https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-medicine-global-market-report

    Ai In Cancer Diagnostics Global Market Report

    https://www.thebusinessresearchcompany.com/report/ai-in-cancer-diagnostics-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Artificial Intelligence In Oncology Market Insights Highlighting Opportunities and Drivers Supporting Growth to 2030

    The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

    How Much Is The Artificial Intelligence In Oncology Market Expected To Grow In Terms Of Market Value Between 2026 And 2030?

    The market size for artificial intelligence in oncology has experienced rapid expansion over recent years. Forecasts indicate it will expand from $2.35 billion in 2025 to $3.13 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 33.4%. Historically, this growth can be ascribed to several factors including rising global cancer incidence rates, an increase in oncology research initiatives, wider adoption of digital pathology, the growing application of data-driven cancer diagnostics, and significant investments in advanced oncology infrastructure.

    The artificial intelligence in oncology market size is set for substantial growth in the upcoming years. It is projected to expand to $10.25 billion by 2030, achieving a compound annual growth rate (CAGR) of 34.5%. This growth throughout the forecast period can be attributed to the increasing uptake of precision oncology solutions, a rising demand for personalized cancer therapies, the expanding use of AI in clinical oncology trials, the growing integration of genomics with AI platforms, and increasing investments in oncology-focused AI startups. Prominent trends expected during this period include the rising adoption of AI-based cancer detection tools, an increased application of AI in optimizing treatment planning, the deepening integration of AI in drug discovery and development, the expansion of predictive oncology analytics, and an enhanced focus on precision oncology applications.

    Download the Free Sample Report to Explore Key Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=13130&type=smp

    What Key Drivers Are Influencing The Growth Of The Artificial Intelligence In Oncology Market?

    The increasing occurrence of cancer is anticipated to fuel the expansion of the AI in oncology market in the future. Cancer constitutes a sophisticated category of illnesses marked by the unregulated proliferation and splitting of unusual cells within the body. Incorporating AI into oncology holds the promise of transforming cancer treatment, enhancing its precision, individualization, and effectiveness. A concrete example is that in 2023, a report from the American Cancer Society Inc., a US-based voluntary health organization, indicated an increase in estimated new cancer cases from 1.8 million to 1.9 million. Consequently, the growing frequency of cancer cases is propelling the growth of the AI in oncology market.

    What Major Segment Divisions Exist Within The Artificial Intelligence In Oncology Market?

    The artificial intelligence in oncology market covered in this report is segmented –

    1) By Component: Software Solutions, Hardware, Services

    2) By Treatment Type: Chemotherapy, Radiotherapy, Immunotherapy, Other Treatment Types

    3) By Cancer Type: Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Brain Tumor, Other Cancer Types

    4) By Application: Cancer Detection, Drug Discovery, Drug Development, Other Applications

    5) By End-Users: Hospitals, Diagnostic Centers, Pharmaceutical Companies, Research Institutes, Other End Users

    Subsegments:

    1) By Software Solutions: Diagnostic Software, Treatment Planning Software, Patient Management Software, Data Analytics Platforms

    2) By Hardware: AI-Enabled Imaging Devices, High-Performance Computing Systems

    3) By Services: Consulting Services, Integration Services, Maintenance And Support Services

    How Are Trends Transforming The Artificial Intelligence In Oncology Market Landscape?

    Key companies operating in the AI in the oncology market are concentrating on producing cutting-edge software, such as cloud-based solutions, to heighten their effectiveness and provide better services. Cloud-based software is fundamental to AI applications in oncology, offering a scalable, adaptable, and accessible platform for processing and analyzing large volumes of medical data. For instance, in March 2023, Illumina Inc., a US-based biotechnology company, introduced Connected Insights, a new cloud-based software facilitating tertiary analysis for oncology applications. Through the integration of external knowledge bases, Connected Insights streamlines the interpretation and reporting of results from diverse assay types, allowing labs to expand their utilization of NGS (Next-Generation Sequencing) and quicken the turnaround time for clinical reporting.

    Which Companies Are Leading Innovation In The Artificial Intelligence In Oncology Market?

    Major companies operating in the artificial intelligence in oncology market are Azra AI, IBM Corporation, Siemens Healthcare GmbH, GE HealthCare, NVIDIA Corporation, Digital Diagnostics Inc., ConcertAI Inc., PathAI Inc., Median Technologies SA, Kheiron Medical Technologies Ltd, Tempus Labs Inc., Paige AI Inc., Prognos Health Inc., Enlitic, Inspirata Inc., Proscia Inc., Deep 6 AI Inc., Intel Corporation, Zebra Medical Vision, Ibex Medical Analytics, Nanox Imaging Ltd., Berg LLC

    Read the full artificial intelligence in oncology market report here:

    https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-oncology-global-market-report

    Which Region Is Expected To Register The Fastest Growth In The Artificial Intelligence In Oncology Market?

    North America was the largest region in the AI in oncology market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence in oncology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request A Tailored Artificial Intelligence In Oncology Market Research Report For Competitive Advantage:

    https://www.thebusinessresearchcompany.com/customise?id=13130&type=smp

    Browse Through More Reports Similar to the Global Artificial Intelligence In Oncology Market 2026, By The Business Research Company

    Artificial Intelligence In Cancer Diagnostics Global Market Report

    https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-cancer-diagnostics-global-market-report

    Artificial Intelligence In Medicine Global Market Report

    https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-medicine-global-market-report

    Ai In Cancer Diagnostics Global Market Report

    https://www.thebusinessresearchcompany.com/report/ai-in-cancer-diagnostics-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Global Artificial Intelligence In Oncology Market Set for Strong Expansion, Reaching $10.24 Billion With 34.5% CAGR by 2030

    Uncover key drivers, emerging technologies, and competitive movements shaping the artificial intelligence in oncology market from 2026–2035 with trusted insights from The Business Research Company

    What total market size is anticipated for the Artificial Intelligence In Oncology Market in 2030?

    The artificial intelligence in oncology market has experienced significant expansion in its size over recent years. It is forecast to grow from $2.35 billion in 2025 to $3.13 billion in 2026, registering a compound annual growth rate (CAGR) of 33.4%. The increase observed historically can be linked to factors such as rising global cancer incidence rates, the proliferation of oncology research initiatives, broader adoption of digital pathology, increasing reliance on data-driven cancer diagnostics, and substantial investments in advanced oncology infrastructure.

    The artificial intelligence in oncology market is projected to experience substantial growth over the coming years. This market is predicted to reach $10.25 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 34.5%. Key drivers for this growth during the forecast period include the increasing uptake of precision oncology solutions, a rising need for personalized cancer treatments, broader utilization of AI in clinical oncology trials, enhanced integration of genomics with AI platforms, and a surge in investments directed towards oncology-focused AI startups. Prominent trends anticipated within this period encompass the growing adoption of AI-based tools for cancer detection, increased application of AI in optimizing treatment plans, greater integration of AI in drug discovery and development processes, the expansion of predictive oncology analytics, and an intensified focus on precision oncology applications.

    Access Your Free Sample Report for In-Depth Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=13130&type=smp

    What Drivers Are Influencing Production Trends In The Artificial Intelligence In Oncology Market?

    The increasing frequency of cancer occurrences is anticipated to drive the expansion of the AI in oncology market going forward. Cancer constitutes an intricate array of illnesses marked by the unregulated proliferation and division of anomalous cells within the body. The adoption of AI in oncology possesses the capacity to fundamentally change cancer care, making it more accurate, individualized, and effective. For example, in 2023, a report from the American Cancer Society Inc., a US-based voluntary health organization, indicated that the estimated number of new cancer cases climbed from 1.8 million to 1.9 million. Hence, the escalating incidence of cancer cases is propelling the growth of the AI in oncology market.

    Which Segment Groups Are Influencing The Artificial Intelligence In Oncology Market?

    The artificial intelligence in oncology market covered in this report is segmented –

    1) By Component: Software Solutions, Hardware, Services

    2) By Treatment Type: Chemotherapy, Radiotherapy, Immunotherapy, Other Treatment Types

    3) By Cancer Type: Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Brain Tumor, Other Cancer Types

    4) By Application: Cancer Detection, Drug Discovery, Drug Development, Other Applications

    5) By End-Users: Hospitals, Diagnostic Centers, Pharmaceutical Companies, Research Institutes, Other End Users

    Subsegments:

    1) By Software Solutions: Diagnostic Software, Treatment Planning Software, Patient Management Software, Data Analytics Platforms

    2) By Hardware: AI-Enabled Imaging Devices, High-Performance Computing Systems

    3) By Services: Consulting Services, Integration Services, Maintenance And Support Services

    Which Trends Are Guiding The Evolution Of The Artificial Intelligence In Oncology Market?

    Leading companies active in the AI in the oncology market are concentrating on developing advanced software, including cloud-based solutions, to improve their effectiveness and offer enhanced solutions. Cloud-based software is essential for AI applications in oncology, delivering a scalable, adaptable, and accessible platform for processing and analyzing extensive medical data. For example, in March 2023, Illumina Inc., a US-based biotechnology company, introduced Connected Insights, a new cloud-based software designed for tertiary analysis in oncology applications. Through the incorporation of external knowledge bases, Connected Insights optimizes the interpretation and reporting of outcomes from various assay types, empowering labs to broaden their utilization of NGS (Next-Generation Sequencing) and expedite the clinical reporting turnaround time.

    Who Are The Core Companies Influencing Trends In The Artificial Intelligence In Oncology Market?

    Major companies operating in the artificial intelligence in oncology market are Azra AI, IBM Corporation, Siemens Healthcare GmbH, GE HealthCare, NVIDIA Corporation, Digital Diagnostics Inc., ConcertAI Inc., PathAI Inc., Median Technologies SA, Kheiron Medical Technologies Ltd, Tempus Labs Inc., Paige AI Inc., Prognos Health Inc., Enlitic, Inspirata Inc., Proscia Inc., Deep 6 AI Inc., Intel Corporation, Zebra Medical Vision, Ibex Medical Analytics, Nanox Imaging Ltd., Berg LLC

    Access The Complete Report For Deeper Market Insights:

    https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-oncology-global-market-report

    Which Regions Are Projected To Dominate The Artificial Intelligence In Oncology Market In The Coming Years?

    North America was the largest region in the AI in oncology market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence in oncology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request Your Customized Artificial Intelligence In Oncology Market Research Report for Competitive Advantage:

    https://www.thebusinessresearchcompany.com/customise?id=13130&type=smp

    Browse Through More Reports Similar to the Global Artificial Intelligence In Oncology Market 2026, By The Business Research Company

    Ai In Cancer Diagnostics Market Report 2026

    https://www.thebusinessresearchcompany.com/report/ai-in-cancer-diagnostics-global-market-report

    Artificial Intelligence In Cancer Diagnostics Market Report 2026

    https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-cancer-diagnostics-global-market-report

    Artificial Intelligence In Medicine Market Report 2026

    https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-medicine-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • What Are The Strategic Insights Behind The Artificial Intelligence In Oncology Market Expansion To $7.55 Billion?

    What Are The Strategic Insights Behind The Artificial Intelligence In Oncology Market Expansion To $7.55 Billion?

    Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

    What Are The Future Growth Projections For The Artificial Intelligence In Oncology Market Size?

    The market size for artificial intelligence in oncology has seen an exponential increase in past years. It is projected to expand from $1.78 billion in 2024 to $2.35 billion in 2025, with a compound annual growth rate (CAGR) of 31.5%. The escalation in the historical period can be linked to the rise in cancer cases, the surge of data in healthcare, optimization of clinical trials, the need for custom-made medicine, as well as efficiency in the fields of radiology and pathology.

    The market for artificial intelligence in oncology is projected to experience a considerable surge in the coming years, expanding to $7.55 billion by 2029 with a CAGR of 34.0%. This anticipated progression for the forecasted timeframe is linked to its incorporation with electronic health records (EHR), its widened use in devising treatment decisions, engaging and educating patients, regulatory backing, and normalization. Noteworthy developments for the projection period involve the adaptation of natural language processing (NLP) in the medical sphere, AI application in the identification of biomarkers, the emphasis on comprehensible AI for clinical assimilation, the integration of AI in managing population health, alliances between AI developers and healthcare providers, and progress in predictive evaluation.

    Get A Free Sample Of The Report:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=13130&type=smp

    Which Demand Drivers Are Strengthening The Artificial Intelligence In Oncology Market?

    The increase in cancer diagnoses is anticipated to drive the expansion of the AI in oncology market. Cancer is a diverse set of diseases marked by the uncontrollable expansion and division of irregular cells in the body. The incorporation of AI into oncology holds the possibility of transforming cancer treatment, making it more accurate, individualized, and efficient. For example, a study by the American Cancer Society Inc., a charity health organization based in the US, showed that in 2023, the projected number of new cancer cases rose from 1.8 million to 1.9 million. Consequently, the growing prevalence of cancer is propelling the AI in oncology market’s development.

    What Segmentation Insights Are Provided In The Artificial Intelligence In Oncology Market Research?

    The artificial intelligence in oncologymarket covered in this report is segmented –

    1) By Component: Software Solutions; Hardware; Services

    2) By Treatment Type: Chemotherapy; Radiotherapy; Immunotherapy; Other Treatment Types

    3) By Cancer Type: Breast Cancer; Lung Cancer; Prostate Cancer; Colorectal Cancer; Brain Tumor; Other Cancer Types

    4) By Application: Cancer Detection; Drug Discovery; Drug Development; Other Applications

    5) By End-Users: Hospitals; Diagnostic Centers; Pharmaceutical Companies; Research Institutes; Other End Users

    Subsegments:

    1) By Software Solutions: Diagnostic Software; Treatment Planning Software; Patient Management Software; Data Analytics Platforms

    2) By Hardware: AI-Enabled Imaging Devices; High-Performance Computing Systems; Wearable Health Monitors

    3) By Services: Consulting Services; Integration Services; Maintenance And Support Services

    Which Trends Are Likely To Redefine Growth Paths In The Artificial Intelligence In Oncology Market?

    Key players in the oncology AI market are concentrating on the creation of innovative software, such as cloud-based versions, to elevate their performance and offer better solutions. In the context of AI applications in oncology, cloud-based software provides an accessible, flexible, and scalable platform for processing and analyzing large amounts of health data. For example, in March 2023, Illumina Inc., a biotechnology firm based in the US, introduced Connected Insights, a novel cloud-based software that facilitates tertiary analysis for oncology applications. Connected Insights simplifies the interpretation and reporting of results from various types of assays through the integration of external knowledge bases, enabling labs to broaden their NGS (Next-Generation Sequencing) use and accelerate the clinical reporting turnaround time.

    Which Firms Are Driving Innovation Within The Artificial Intelligence In Oncology Market?

    Major companies operating in the artificial intelligence in oncology market report are Azra AI, IBM Corporation, Siemens Healthcare GmbH, Intel Corporation, GE HealthCare, NVIDIA Corporation, Digital Diagnostics Inc., ConcertAI Inc., PathAI Inc., Median Technologies SA, Kheiron Medical Technologies Ltd., Hampton Research Inc., Tempus Labs Inc., Paige AI Inc., Prognos Health Inc., Enlitic, Inspirata Inc., Berg LLC, Proscia Inc., Prognos Health Inc., Deep 6 AI Inc., Ibex Medical Analytics, Nanox Imaging Ltd., Zebra Medical Vision, Globavir Biosciences Inc.

    Access The Complete Report Here:

    https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-oncology-global-market-report

    Which Regional Markets Are Emerging As Key Hubs For The Artificial Intelligence In Oncology Market?

    North America was the largest region in the AI in oncology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence in oncology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

    Customize Your Report Here:

    https://www.thebusinessresearchcompany.com/customise?id=13130&type=smp

    Browse Through More Reports Similar to the Global Artificial Intelligence In Oncology Market 2025, By The Business Research Company

    Artificial Intelligence In E Commerce Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-e-commerce-global-market-report

    Artificial Intelligence In Military Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-military-global-market-report

    Artificial Intelligence In Marketing Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-marketing-global-market-report

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Artificial Intelligence In Oncology Industry Overview 2025: Growth Projections and Market Trends

    Artificial Intelligence In Oncology Industry Overview 2025: Growth Projections and Market Trends

    Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

    What Is The Future Market Size Estimation For The Artificial Intelligence In Oncology Market Covering 2025–2034?

    The artificial intelligence in oncology market size has experienced rapid expansion in recent years. This market is projected to expand from $1.78 billion in 2024 to $2.35 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 31.5%. Historically, this increase can be linked to factors such as a rise in cancer cases, the increasing volume of data in healthcare, advancements in optimizing clinical trials, the growing need for personalized medical treatments, and enhanced efficiency in both radiology and pathology.

    The artificial intelligence in oncology market is projected to experience rapid expansion over the upcoming years. This market is anticipated to reach $7.55 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 34.0%. Several factors will contribute to this expansion during the forecast period, including integration with electronic health records (EHR), broader applications in treatment decision support, patient engagement and education initiatives, regulatory backing, and standardization efforts. Key trends observed during this period involve the incorporation of natural language processing (NLP) within healthcare, the use of AI in biomarker discovery, an emphasis on explainable AI for wider clinical acceptance, the integration of AI into population health management, partnerships between AI developers and healthcare providers, and progress in predictive analytics.

    Unlock Your Free Sample Report for Exclusive Market Data:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=13130&type=smp

    Which Major Market Drivers Are Shaping The Future Of The Artificial Intelligence In Oncology Market?

    The increasing occurrence of cancer cases is anticipated to spur the advancement of the AI in oncology market moving forward. Cancer constitutes a complex set of diseases characterized by the unchecked proliferation and division of atypical cells within the body. The integration of AI into oncology possesses the potential to revolutionize cancer care by enhancing its precision, personalization, and efficiency. For instance, in 2023, according to a report by the American Cancer Society Inc., a US-based voluntary health organization, the estimated number of new cancer cases rose from 1.8 million to 1.9 million. Consequently, the escalating incidence of cancer cases is propelling the growth of the AI in oncology market.

    What Are The Major Segments Identified In The Artificial Intelligence In Oncology Market?

    The artificial intelligence in oncologymarket covered in this report is segmented –

    1) By Component: Software Solutions; Hardware; Services

    2) By Treatment Type: Chemotherapy; Radiotherapy; Immunotherapy; Other Treatment Types

    3) By Cancer Type: Breast Cancer; Lung Cancer; Prostate Cancer; Colorectal Cancer; Brain Tumor; Other Cancer Types

    4) By Application: Cancer Detection; Drug Discovery; Drug Development; Other Applications

    5) By End-Users: Hospitals; Diagnostic Centers; Pharmaceutical Companies; Research Institutes; Other End Users

    Subsegments:

    1) By Software Solutions: Diagnostic Software; Treatment Planning Software; Patient Management Software; Data Analytics Platforms

    2) By Hardware: AI-Enabled Imaging Devices; High-Performance Computing Systems; Wearable Health Monitors

    3) By Services: Consulting Services; Integration Services; Maintenance And Support Services

    How Are Emerging Market Trends Shaping The Artificial Intelligence In Oncology Industry Landscape?

    Key companies operating in the AI in the oncology market are concentrating on developing innovative software, such as cloud-based solutions, to enhance their effectiveness and provide improved offerings. Cloud-based software plays a critical role in AI applications in oncology by offering a scalable, adaptable, and accessible platform for processing and analyzing vast amounts of medical data. For instance, in March 2023, Illumina Inc., a US-based biotechnology company, launched Connected Insights, a new cloud-based software enabling tertiary analysis for oncology applications. Through the integration of external knowledge bases, Connected Insights streamlines the interpretation and reporting of results from various assay types, allowing laboratories to expand their utilization of NGS (Next-Generation Sequencing) and speed up the turnaround time for clinical reporting.

    Which Major Industry Participants Are Leading The Artificial Intelligence In Oncology Market Growth?

    Major companies operating in the artificial intelligence in oncology market report are Azra AI, IBM Corporation, Siemens Healthcare GmbH, Intel Corporation, GE HealthCare, NVIDIA Corporation, Digital Diagnostics Inc., ConcertAI Inc., PathAI Inc., Median Technologies SA, Kheiron Medical Technologies Ltd., Hampton Research Inc., Tempus Labs Inc., Paige AI Inc., Prognos Health Inc., Enlitic, Inspirata Inc., Berg LLC, Proscia Inc., Prognos Health Inc., Deep 6 AI Inc., Ibex Medical Analytics, Nanox Imaging Ltd., Zebra Medical Vision, Globavir Biosciences Inc.

    Download The Full Report For Exclusive Market Findings:

    https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-oncology-global-market-report

    Which Regional Markets Are Contributing Most To The Artificial Intelligence In Oncology Industry Expansion?

    North America was the largest region in the AI in oncology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence in oncology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

    Request A Customized Version Of The Artificial Intelligence In Oncology Market Report:

    https://www.thebusinessresearchcompany.com/customise?id=13130&type=smp

    Browse Through More Reports Similar to the Global Artificial Intelligence In Oncology Market 2025, By The Business Research Company

    Artificial Intelligence In E Commerce Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-e-commerce-global-market-report

    Artificial Intelligence In Military Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-military-global-market-report

    Artificial Intelligence In Marketing Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-marketing-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Artificial Intelligence In OncologyMarket Overview 2025–2034: CAGR Trends, Long-Term Growth Paths, and Business Implications

    Artificial Intelligence In OncologyMarket Overview 2025–2034: CAGR Trends, Long-Term Growth Paths, and Business Implications

    Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

    How Has The Artificial Intelligence In Oncology Market Growth Evolved From 2024 To 2025, And What’s Ahead?

    In recent times, the size of the market for artificial intelligence in oncology has seen substantial growth. This market is projected to increase from $1.78 billion in 2024 to $2.35 billion in 2025, with a compound annual growth rate (CAGR) of 31.5%. This growth during the historic period is the outcome of escalated incidences of cancer, data accumulation in medical fields, optimization of clinical trials, rising demand for personalized medicinal approach, and enhanced efficiency in the branches of radiology and pathology.

    The market for artificial intelligence in oncology is predicted to experience substantial growth in the coming years, expanding to $7.55 billion by 2029 at a compound annual growth rate (CAGR) of 34.0%. The escalation during the forecast period can be ascribed to the amalgamation with electronic health records (EHR), broadening uses in treatment decision assistance, patient involvement and enlightenment, regulatory backing, and normalization. Key trends for the forecast duration include the incorporation of natural language processing (NLP) in healthcare, the application of AI in biomarker detection, emphasis on interpretable AI for clinical integration, the inclusion of AI in population health administration, partnerships between AI developers and healthcare providers, and progression in predictive analytics.

    Download a free sample to assess the report’s scope and structure:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=13130&type=smp

    What Are the Primary Drivers Supporting the Market Growth of the Artificial Intelligence In Oncology Market?

    The anticipated surge in cancer occurrences is predicted to propel the expansion of the AI in oncology industry. Cancer, a complicated array of illnesses, is marked by uncontrolled cell growth and division. The incorporation of AI into oncology holds the potential to significantly transform cancer treatment by enhancing precision, personalization, and efficiency. For instance, per a report from the American Cancer Society Inc., a voluntary health organization based in the US, the forecasted number of new cancer cases rose from 1.8 million to 1.9 million in 2023. Consequently, the increasing prevalence of cancer is stimulating the progress of the AI in oncology industry.

    Which Primary Segments of the Artificial Intelligence In Oncology Market Are Driving Growth and Industry Transformations?

    The artificial intelligence in oncologymarket covered in this report is segmented –

    1) By Component: Software Solutions; Hardware; Services

    2) By Treatment Type: Chemotherapy; Radiotherapy; Immunotherapy; Other Treatment Types

    3) By Cancer Type: Breast Cancer; Lung Cancer; Prostate Cancer; Colorectal Cancer; Brain Tumor; Other Cancer Types

    4) By Application: Cancer Detection; Drug Discovery; Drug Development; Other Applications

    5) By End-Users: Hospitals; Diagnostic Centers; Pharmaceutical Companies; Research Institutes; Other End Users

    Subsegments:

    1) By Software Solutions: Diagnostic Software; Treatment Planning Software; Patient Management Software; Data Analytics Platforms

    2) By Hardware: AI-Enabled Imaging Devices; High-Performance Computing Systems; Wearable Health Monitors

    3) By Services: Consulting Services; Integration Services; Maintenance And Support Services

    Request customized data on this market:

    https://www.thebusinessresearchcompany.com/customise?id=13130&type=smp

    Which Regions Are Key Players in the Growth of the #What Are the Primary Drivers Supporting the Market Growth of the Artificial Intelligence In Oncology Market?# Market?

    North America was the largest region in the AI in oncology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence in oncology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

    What Are the Most Significant Market Trends in the Artificial Intelligence In Oncology Market?

    Key industry players in the AI oncology market are concentrating their efforts on innovating new software, including cloud-based applications, to boost their effectiveness and deliver better solutions. Cloud-based software is critical in AI-driven oncology applications as it offers a scalable, flexible and readily available platform for processing and interpreting vast amounts of medical information. In March 2023, Illumina Inc., a biotech firm based in the U.S., rolled out Connected Insights, a fresh cloud-based software that simplifies tertiary analysis for oncology applications. Incorporation of external knowledge bases in Connected Insights simplifies the interpretation and reporting of results from different assay types, enabling laboratories to maximize their utilization of NGS (Next-Generation Sequencing) and expedite the turnaround time for clinical reports.

    View the full report here:

    https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-oncology-global-market-report

    What Parameters Are Used to Define the Artificial Intelligence In Oncology Market?

    Artificial intelligence in oncology refers to applying artificial intelligence (AI) technologies and techniques in cancer diagnosis, treatment, research, and patient care. The goal of AI in oncology is to improve outcomes for cancer patients by leveraging computational methods to identify patterns, predict outcomes, and support evidence-based decision-making across the continuum of cancer care.

    Purchase the full report and get a swift delivery:

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13130

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Europe +44 7882 955267

    Asia & Others +44 7882 955267 & +91 8897263534

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model